| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 17,180 | $30 | $584K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 30,300 | $10 | $333.3K |
| J3262 | Injection, tocilizumab, 1 mg | 41,680 | $10 | $208.4K |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 37,200 | $1 | $148.8K |
| J0897 | Injection, denosumab, 1 mg | 4,680 | $20 | $84.2K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 620 | $90 | $54.2K |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 5,250 | $10 | $42K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 340 | $100 | $33.6K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 180 | $60 | $10.8K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 210 | $50 | $10.2K |